Coronaviridae |
HCoV-229E |
Alphacoronavirus |
(+)ssRNA Enveloped |
Respiratory droplets and close contact |
CD13 |
Cell plasma membrane fusion; Caveolae-mediated endocytosis |
Mild self-limiting respiratory infection and pneumonia colds |
Nomura et al., 2004; Goh et al., 2012; Fehr et al., 2016
|
HCoV-NL63 |
Alphacoronavirus |
(+)ssRNA Enveloped |
Close contact |
ACE2 |
Cell plasma membrane fusion; Clathrin-mediated endocytosis |
Mild self-limiting respiratory infection and pneumonia colds |
Goh et al., 2012; Fehr et al., 2016; Milewska et al., 2018
|
HCoV-OC43 |
Betacoronavirus |
(+)ssRNA Enveloped |
Respiratory droplets |
N-acetyl-9-O-acetylneuraminic |
Cell plasma membrane fusion; Caveolae-mediated endocytosis |
Mild self-limiting respiratory infection |
Owczarek et al., 2018; Fehr et al., 2016
|
HCoV-HKU1 |
Betacoronavirus |
(+)ssRNA Enveloped |
Close contact |
O-acetylated sialic acid |
Cell plasma membrane fusion; Endocytotic pathway |
Mild self-limiting respiratory infection |
Goh et al., 2012; Fehr et al., 2016
|
SARS-CoV |
Betacoronavirus |
(+)ssRNA Enveloped |
Direct contact with infected individuals |
ACE2 |
Cell plasma membrane fusion; Clathrin-mediated endocytosis; Clathrin and caveolae indipendent uptake |
Severe acute respiratory syndrome |
Lu et al., 2008; Wang et al., 2008; Fehr et al., 2016; World Health Organization [WHO], 2020
|
MERS-CoV |
Betacoronavirus |
(+)ssRNA Enveloped |
Primarly from infected dromedaries and camels to people; Between people after close unprotected contact |
DPP4 |
Cell plasma membrane fusion; Clathrin mediated endocytosis |
Severe acute respiratory disease |
Fehr et al., 2016; Al-Qahtani et al., 2017; Liang et al., 2018; World Health Organization [WHO], 2020
|
SARS-CoV2 |
Betacoronavirus |
(+)ssRNA Enveloped |
Airborne; Respiratory droplets and close contact |
ACE2 |
Cell plasma membrane fusion; Endocytosis mediated pathway |
Severe acute respiratory disease |
Wang et al., 2008; Fehr et al., 2016; World Health Organization [WHO], 2020
|
Flaviviridae |
HCV |
Hepacivirus |
(+)ssRNA Enveloped |
Bloodborne |
CD81; LDLR; SR-B1; CLDN1; OCLN |
Receptor-mediated endocytosis |
Acute and chronic hepatopathy; Liver cancer |
Andrus and East, 2010; Colpitts et al., 2020; World Health Organization [WHO], 2020
|
DENV |
Flavivirus |
(+)ssRNA Enveloped |
Mosquito-borne |
Unidentified universal cell-surface receptor |
Clathrin-mediated endocytosis |
Acute flu-like illness; Severe dengue |
Martinez-Gutierrez et al., 2011 |
WNV |
Flavivirus |
(+)ssRNA Enveloped |
Mosquito-borne |
DC-SIGN; Mannose receptor |
Clathrin-mediated endocytosis |
Fatal neurological disease |
Colpitts et al., 2012; Vancini et al., 2013; Fares-Gusmao et al., 2019
|
ZIKV |
Flavivirus |
(+) ssRNA Enveloped |
Mosquito-borne |
DC-SIGN; TIM-1; AXL |
Clathrin-mediated endocytosis |
Mild, often asymptomatic illness; Congenital malformations in infants when contracted during pregnancy |
Laureti et al., 2018; Fares-Gusmao et al., 2019
|
Filoviridae |
EBOV |
Ebolavirus |
(−)ssRNA Enveloped |
Blood, secretions, bodily fluids of infected people; Contaminated surfaces and materials |
TIM-1; NPC1 |
Macropinocytosis |
Hemorrhagic fever |
Salata et al., 2019; World Health Organization [WHO], 2020
|
Orthomyxoviridae |
IAV |
Alphainfluenzavirus |
(−)ssRNA Enveloped |
Respiratory droplets |
N-acetylneuraminic acid (sialic acid) |
Receptor mediated endocytosis |
Acute respiratory infections of varying severity |
Edinger et al., 2014; World Health Organization [WHO], 2020
|